TANGO THERAPEUTICS INC (TNGX)
US87583X1090 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 37.04M | 24.86M -32.88% | 36.527M 46.93% | 46.657M 27.73% | 28.972M -37.90% | 25.498M -11.99% | 25.018M -1.88% | 103.95M 315.50% | 260.58M 150.68% | 438.85M 68.41% | 671.94M 53.11% | |
| EBITDA YoY % growth | -57.29M | -109.46M -91.06% | -111.758M -2.10% | -147.48M -31.96% | -229.966M -55.93% | -259.41M -12.80% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -58.19M -32,227.78% | -111.07M -90.87% | -114.173M -2.79% | -147.294M -29.01% | -183.581M -24.64% | -207.65M -13.11% | -218.634M -5.29% | -176.936M 19.07% | -55.657M 68.54% | 86.799M 255.95% | 311.57M 258.96% | |
| Operating Margin | -157.10% | -446.78% | -312.57% | -315.70% | -633.65% | -814.38% | -873.91% | -170.21% | -21.36% | 19.78% | 46.37% | |
| EPS YoY % growth | N/A | -1.23 -13.55% | -1.10 10.57% | -1.22 -11.34% | -1.45 -18.71% | -1.51 -3.66% | -1.75 -16.14% | -1.52 13.02% | -0.48 68.73% | 0.51 206.43% | 2.46 385.20% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.35 -7.83% | -0.37 -5.91% | -0.37 -56.06% | -0.38 -40.00% | -0.38 -9.37% |
| Revenue Q2Q % growth | 7.922M 45.87% | 7.525M 16.29% | 7.031M -64.62% | 7.031M -39.42% | 7.132M -9.97% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -40.487M -15.63% | -44.62M -5.60% | -46.161M -56.20% | -47.521M -44.54% | -46.619M -15.15% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.27 -17.39% | -0.37 | 0.10 | 27.91% |
| Q2 2024 Q2Q % growth | -0.24 -4.35% | -0.35 | 0.11 | 31.80% |
| Q1 2024 Q2Q % growth | -0.35 -9.37% | -0.32 | -0.03 | -9.71% |
| Q4 2023 Q2Q % growth | -0.32 3.03% | -0.28 | -0.04 | -12.95% |
| Q3 2023 Q2Q % growth | -0.23 30.30% | -0.35 | 0.12 | 34.64% |
| Q2 2023 Q2Q % growth | -0.23 17.86% | -0.34 | 0.11 | 32.89% |
| Q1 2023 Q2Q % growth | -0.32 -10.34% | -0.36 | 0.04 | 10.70% |
| Q4 2022 Q2Q % growth | -0.33 -32.00% | -0.36 | 0.03 | 8.86% |
| Q3 2022 Q2Q % growth | -0.33 -17.86% | -0.33 | 0.00 | -0.06% |
| Q2 2022 Q2Q % growth | -0.28 | -0.33 | 0.05 | 15.27% |
| Q1 2022 Q2Q % growth | -0.29 | -0.28 | -0.01 | -2.27% |
| Q4 2021 Q2Q % growth | -0.25 | -0.28 | 0.03 | 9.22% |
| Q3 2021 Q2Q % growth | -0.28 | -0.29 | 0.01 | 2.66% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 11.607M 8.15% | 7.965M | 3.642M | 45.73% |
| Q2 2024 Q2Q % growth | 19.875M 36.15% | 7.571M | 12.304M | 162.51% |
| Q1 2024 Q2Q % growth | 6.471M 12.23% | 6.805M | -334K | -4.91% |
| Q4 2023 Q2Q % growth | 5.431M -15.27% | 8.408M | -2.977M | -35.41% |
| Q3 2023 Q2Q % growth | 10.732M 55.09% | 7.465M | 3.267M | 43.76% |
| Q2 2023 Q2Q % growth | 14.598M 153.00% | 7.089M | 7.509M | 105.92% |
| Q1 2023 Q2Q % growth | 5.766M 0.10% | 6.842M | -1.076M | -15.73% |
| Q4 2022 Q2Q % growth | 6.41M 12.06% | 6.566M | -156K | -2.38% |
| Q3 2022 Q2Q % growth | 6.92M 1.91% | 5.646M | 1.274M | 22.56% |
| Q2 2022 Q2Q % growth | 5.77M -76.49% | 5.773M | -3K | -0.05% |
| Q1 2022 Q2Q % growth | 5.76M | 5.951M | -191K | -3.21% |
| Q4 2021 Q2Q % growth | 5.72M | 6.589M | -869K | -13.19% |
| Q3 2021 Q2Q % growth | 6.79M | 6.452M | 338K | 5.24% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0.86% | 0% | 9.52% |
| Revenue | 0% | -5.44% | 0% | 8.11% |